132 filings
Page 3 of 7
6-K
umvzkk4jrrr6x1v0j3f
14 Jul 23
Current report (foreign)
12:17pm
6-K
6gtnx3dn
12 Jul 23
PainReform Announces Pricing of $2.7 Million Concurrent Registered Direct Offering and Private Placement
9:23am
6-K
ltnujcp
29 Jun 23
Current report (foreign)
4:01pm
6-K
7nhnp6b6t
8 Jun 23
Current report (foreign)
4:30pm
6-K
mcgcjy gipw7
7 Jun 23
PainReform Provides Regulatory Update on Second Part of its Phase 3 Clinical Trial of
4:33pm
6-K
vzjztn6q
18 May 23
PainReform Announces Positive Pharmacokinetic (PK) Data in First Part of Phase 3
9:10am
6-K
ee75o9 6f
15 May 23
Condensed Financial Statements
4:51pm
6-K/A
k9ajohdhi hfp
4 May 23
Annual General Meeting of Shareholders to Be
8:19am
6-K
dmfqpt cnnpbl2qdj
3 May 23
Annual General Meeting of Shareholders to Be
5:25pm
6-K
8rcadhv90hlkq7umek8l
1 May 23
PainReform Announces Positive Safety Data in First Part of Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy Surgery
8:41am
6-K
c6z53o xehqbqw
28 Mar 23
PainReform Completes First Part of Phase 3 Clinical Trial in Patients Undergoing Bunionectomy Surgery
9:16am
6-K
c11rlota896rhofrsdk
16 Mar 23
Current report (foreign)
8:09am
6-K
cgfullg
14 Mar 23
PainReform Announces Commencement of Phase 3 Clinical Trial to Evaluate PRF-110 in Patients Undergoing Bunionectomy Surgery
8:05am
6-K
0ftz ujcvjhow1jlkpv
7 Feb 23
Current report (foreign)
4:11pm
6-K
0y3uc
29 Dec 22
Current report (foreign)
4:31pm
6-K
vcu3zp tlrplgu1
25 Nov 22
Annual General Meeting of Shareholders to Be
4:30pm
6-K
426 pjbicl05uqsttgck
15 Nov 22
PainReform Provides Business Update for the Third Quarter of 2022
8:47am
6-K
tii1jza
14 Nov 22
Condensed Financial Statements
5:02pm
6-K
jman1b12r56qbv6nx0nh
8 Nov 22
PainReform Provides Further Update on Manufacturing of PRF-110
8:42am